|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
CAOONL|ncf11544958
(VIAF cluster)
|
|
003
|
|
|
CAOONL |
|
005
|
|
|
20200415000000.0 |
|
008
|
|
|
100420n|fa|vnnaabn || aaa d |
|
035
|
|
|
‡a
(CAOONL)ncf11544958
|
|
035
|
|
|
‡a
(CaOONL)ncf11544958
|
|
035
|
|
|
‡a
(CaQQLA)NO2010065307
|
|
040
|
|
|
‡a
CaQQLA
‡b
fre
‡c
CaQQLA
|
|
100
|
1 |
|
‡a
Smith, Kelly M.
|
|
670
|
|
|
‡a
Clinical drug data, c2010:
‡b
t.p. (Kelly M. Smith, PharmD, BCPS, FASHP, FCCP; assoc. dean, Academic & Student Affairs Practice; assoc. prof., Pharmacy Practice & Science, Univ. of Kentucky College of Pharmacy)
|
|
919
|
|
|
‡a
clinicaldrugdata
‡A
Clinical drug data, c2010:
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2010
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000140664467
|
|
996
|
|
|
‡2
DNB|1137896604
|
|
996
|
|
|
‡2
WKP|Q91239689
|
|
996
|
|
|
‡2
LC|nr2006030555
|
|
996
|
|
|
‡2
WKP|Q67428724
|
|
996
|
|
|
‡2
BNF|16673067
|
|
996
|
|
|
‡2
LC|no2015061240
|
|
996
|
|
|
‡2
WKP|Q91430943
|
|
996
|
|
|
‡2
DBC|87097969700489
|
|
996
|
|
|
‡2
PLWABN|9814283098405606
|
|
996
|
|
|
‡2
WKP|Q9675
|
|
996
|
|
|
‡2
WKP|Q98947193
|
|
996
|
|
|
‡2
NKC|xx0187703
|
|
996
|
|
|
‡2
DNB|1170281419
|
|
996
|
|
|
‡2
RERO|A013597656
|
|
996
|
|
|
‡2
DNB|121382222X
|
|
996
|
|
|
‡2
BNF|16569493
|
|
996
|
|
|
‡2
ISNI|0000000366012381
|
|
996
|
|
|
‡2
SUDOC|179893807
|
|
996
|
|
|
‡2
RERO|A003839563
|
|
996
|
|
|
‡2
ISNI|0000000023081211
|
|
996
|
|
|
‡2
LC|n 2023027178
|
|
996
|
|
|
‡2
LC|nb2021011459
|
|
996
|
|
|
‡2
ISNI|000000005481772X
|
|
996
|
|
|
‡2
BNF|16915828
|
|
996
|
|
|
‡2
WKP|Q6385907
|
|
996
|
|
|
‡2
ISNI|0000000472406894
|
|
996
|
|
|
‡2
J9U|987007409207705171
|
|
996
|
|
|
‡2
ISNI|0000000076150778
|
|
996
|
|
|
‡2
LC|no2013133598
|
|
996
|
|
|
‡2
WKP|Q79137365
|
|
996
|
|
|
‡2
BIBSYS|90058978
|
|
996
|
|
|
‡2
SUDOC|273204092
|
|
996
|
|
|
‡2
WKP|Q95894322
|
|
996
|
|
|
‡2
BIBSYS|90157611
|
|
996
|
|
|
‡2
NUKAT|n 2009096254
|
|
996
|
|
|
‡2
LC|no2002081566
|
|
996
|
|
|
‡2
SUDOC|279578369
|
|
996
|
|
|
‡2
WKP|Q6386201
|
|
996
|
|
|
‡2
NDL|01195942
|
|
996
|
|
|
‡2
ISNI|0000000387070185
|
|
996
|
|
|
‡2
WKP|Q89281961
|
|
996
|
|
|
‡2
WKP|Q57515386
|
|
996
|
|
|
‡2
LC|n 85244652
|
|
996
|
|
|
‡2
WKP|Q60651400
|
|
996
|
|
|
‡2
WKP|Q110635033
|
|
996
|
|
|
‡2
LC|no2019074334
|
|
996
|
|
|
‡2
WKP|Q96621031
|
|
996
|
|
|
‡2
N6I|vtls000283667
|
|
996
|
|
|
‡2
NTA|069038767
|
|
996
|
|
|
‡2
SUDOC|167748742
|
|
996
|
|
|
‡2
LC|no2010135755
|
|
996
|
|
|
‡2
BIBSYS|1686548388910
|
|
996
|
|
|
‡2
WKP|Q127599890
|
|
996
|
|
|
‡2
BIBSYS|13041812
|
|
996
|
|
|
‡2
LC|nb2009023596
|
|
996
|
|
|
‡2
BNF|16541284
|
|
996
|
|
|
‡2
LC|n 2008029368
|
|
996
|
|
|
‡2
NTA|241526051
|
|
996
|
|
|
‡2
WKP|Q6386301
|
|
996
|
|
|
‡2
ISNI|0000000096384766
|
|
996
|
|
|
‡2
LC|no2013104533
|
|
996
|
|
|
‡2
LC|no2016055373
|
|
996
|
|
|
‡2
LC|n 2023019351
|
|
996
|
|
|
‡2
WKP|Q130212950
|
|
996
|
|
|
‡2
LC|n 83319147
|
|
996
|
|
|
‡2
WKP|Q52055719
|
|
996
|
|
|
‡2
WKP|Q84978327
|
|
996
|
|
|
‡2
WKP|Q114529095
|
|
996
|
|
|
‡2
LC|nb2003008225
|
|
996
|
|
|
‡2
WKP|Q6386256
|
|
996
|
|
|
‡2
WKP|Q95988511
|
|
996
|
|
|
‡2
LC|nr 94033841
|
|
996
|
|
|
‡2
ISNI|000000039220167X
|
|
996
|
|
|
‡2
WKP|Q107582702
|
|
996
|
|
|
‡2
ISNI|0000000123277086
|
|
996
|
|
|
‡2
WKP|Q67388469
|
|
996
|
|
|
‡2
WKP|Q104704539
|
|
996
|
|
|
‡2
SUDOC|281025126
|
|
996
|
|
|
‡2
ISNI|0000000402992891
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Smith, Kelly M.
‡2
LC|no2010065307
‡3
exact title: (1.00, 'clinicaldrugdata', 'clinicaldrugdata')
|
|
998
|
|
|
‡a
Smith, Kelly M
‡2
NDL|01195942
‡3
exact name
|
|
998
|
|
|
‡a
Smith, Kelly M.
‡2
J9U|987007409207705171
‡3
viafid
|
